These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 12665908

  • 1. [Genotyping of hepatitis B virus and clinical investigation].
    Wang Y, Zhou G, Li X, Zhou Z, Zhou S, Ruan L, Chen M, Deng W.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):367-9. PubMed ID: 12665908
    [Abstract] [Full Text] [Related]

  • 2. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP, Li LJ, Du WB, Li MW, Cao HC, Sheng JF.
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [Abstract] [Full Text] [Related]

  • 3. [Distribution of hepatitis B virus genotypes and its clinical significance in Guangxi].
    Ge XM, Li DY, Fang ZL, Huang GY, Jiang SQ, Pan HD, Du Y, Wang CY, Ding X, Masashi M.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Jun; 17(2):174-9. PubMed ID: 12870004
    [Abstract] [Full Text] [Related]

  • 4. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J, Sriplung H, Chongsuvivatwong V, Geater A, Zhuang L, Huang JH, Chen HY, Yu L, Tang BZ.
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [Abstract] [Full Text] [Related]

  • 5. HBV genotype characterization and distribution in patients with HBV-related liver diseases in Zhejiang Province, P.R. China: possible association of co-infection with disease prevalence and severity.
    Zumbika E, Ruan B, Xu CH, Ni Q, Hou W, Chen Z, Liu KZ.
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):535-43. PubMed ID: 16286258
    [Abstract] [Full Text] [Related]

  • 6. Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance.
    Moskovitz DN, Osiowy C, Giles E, Tomlinson G, Heathcote EJ.
    J Viral Hepat; 2005 Jul; 12(4):398-404. PubMed ID: 15985011
    [Abstract] [Full Text] [Related]

  • 7. [Investigation on virus genotype in patients infected with hepatitis B virus in four cities of Guizhou].
    Ding Jj, Zhang Q, Peng L, Liu YH, Li Z, Liu SD, Hu L.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Nov; 27(11):977-80. PubMed ID: 17402202
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma.
    Yuen MF, Sablon E, Yuan HJ, Wong DK, Hui CK, Wong BC, Chan AO, Lai CL.
    Hepatology; 2003 Mar; 37(3):562-7. PubMed ID: 12601354
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudine.
    Yuen MF, Wong DK, Sablon E, Yuan HJ, Sum SM, Hui CK, Chan AO, Wang BC, Lai CL.
    Antivir Ther; 2003 Dec; 8(6):531-4. PubMed ID: 14760886
    [Abstract] [Full Text] [Related]

  • 13. HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.
    Di Marco V, Di Stefano R, Ferraro D, Almasio PL, Bonura C, Giglio M, Parisi P, Cappello M, Alaimo G, Craxì A.
    Antivir Ther; 2005 Dec; 10(3):431-9. PubMed ID: 15918334
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Effects comparison of lamivudine therapy for hepatitis B virus genotypes B and C].
    Zhou JL, Wu SP.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):489-90. PubMed ID: 15329211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK, Comanor L, White C, Kipnis P, Elkin C, Leung K, Ocampo A, Attar N, Keiser P, Lee WM.
    J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.